缺血性中风和额外心肌损伤患者的认知表现 - 多中心前性观察性PRAISE研究的结果
Regina von Rennenberg1,2,3, Simon Litmeier4,5, Kristina Szabo6
1Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany. regina-irene.freiin-von-rennenberg@charite.de.
Neurological research and practice
|November 4, 2025
概括
心肌损伤的严重程度,而不是急性损伤,与中风患者的认知障碍有关. 较高的心脏托罗邦素水平与中风后认知功能较差相关.
科学领域:
- 心脏病学和神经病学
- 在中风中的生物标志物
- 认知障碍研究 认知障碍研究
背景情况:
- 认知障碍和痴呆症在以前患有心肌损伤 (心脏高敏感性肌素升高,hs-cTn) 的个体中更为普遍.
- 关于心肌损伤与认知结果之间关系的数据有限,特别是在中风患者中.
- 这项研究调查了急性缺血性中风后心肌损伤严重程度和认知表现之间的关联.
研究的目的:
- 分析急性缺血性中风后心肌损伤程度 (hs-cTn升高) 与认知表现之间的关联.
- 为了确定急性心肌损伤的存在 (动态hs-cTn变化) 是否会影响认知结果.
- 评估脑卒中患者随时间推移的认知表现,患者心肌损伤程度各不相同.
主要方法:
- 对前性,多中心观测性PRAISE研究的一项预先规定的分析,该研究涉及254名急性缺血性中风或TIA心肌损伤患者.
- 认知评估是在基线,医院出院 (蒙特利尔认知评估,MoCA) 和3个月和12个月 (认知状态电话采访,TICS) 进行的.
- 线性回归和通用线性模型被用来分析hs-cTn水平,急性心肌损伤和随时间推移的认知得分之间的关联.
主要成果:
- 更严重的心肌损伤与较低的MoCA得分 (调整后的β-2.6) 和较高比例的认知障碍 (调整后的OR 2.9) 有关.
- 急性心肌损伤的存在与更好的认知表现有关 (调整后β1.8).
- 在12个月的时间里,hs-cTn水平和认知能力下降之间没有发现显著的关联.
结论:
- 在患有缺血性中风的患者中,心肌损伤的整体严重程度与认知障碍有关.
- 在中风时出现急性心肌损伤似乎与认知障碍无关.
- 需要进一步的研究,以了解结合心肌损伤严重程度和中风幸存者的认知结果的机制.
相关概念视频
Ischemic Heart Disease: Overview
2.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.8K
Acute Coronary Syndrome III: Diagnostic Studies
204
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
204
Acute Coronary Syndrome IV: Interprofessional Care
211
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
211
Acute Coronary Syndrome I: Introduction
772
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
772
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
340
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
340
Coronary Artery Disease III: Clinical Manifestations
314
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
314


